149 related articles for article (PubMed ID: 14694980)
1. Paratesticular mesothelial proliferations.
Churg A
Semin Diagn Pathol; 2003 Nov; 20(4):272-8. PubMed ID: 14694980
[TBL] [Abstract][Full Text] [Related]
2. Mesothelioma of the tunica vaginalis: a series of eight cases with uncertain malignant potential.
Brimo F; Illei PB; Epstein JI
Mod Pathol; 2010 Aug; 23(8):1165-72. PubMed ID: 20526287
[TBL] [Abstract][Full Text] [Related]
3. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: a clinicopathologic study of 12 cases.
Lee S; Illei PB; Han JS; Epstein JI
Am J Surg Pathol; 2014 Jan; 38(1):54-9. PubMed ID: 24061516
[TBL] [Abstract][Full Text] [Related]
4. The separation of benign and malignant mesothelial proliferations.
Churg A; Colby TV; Cagle P; Corson J; Gibbs AR; Gilks B; Grimes M; Hammar S; Roggli V; Travis WD
Am J Surg Pathol; 2000 Sep; 24(9):1183-200. PubMed ID: 10976692
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis.
Chekol SS; Sun CC
Arch Pathol Lab Med; 2012 Jan; 136(1):113-7. PubMed ID: 22208496
[TBL] [Abstract][Full Text] [Related]
6. Paratesticular papillary mesothelioma: a case with borderline features.
Cabay RJ; Siddiqui NH; Alam S
Arch Pathol Lab Med; 2006 Jan; 130(1):90-2. PubMed ID: 16390245
[TBL] [Abstract][Full Text] [Related]
7. Testicular/paratesticular mesothelial tumours: Uncommon histopathologic entities in a very complex anatomical site.
Pagliuca F; Lucà S; De Sio M; Arcaniolo D; Facchini G; De Martino M; Esposito F; DE Vita F; Chieffi P; Franco R
Pathol Res Pract; 2024 Jan; 253():155069. PubMed ID: 38181581
[TBL] [Abstract][Full Text] [Related]
8. Well differentiated (benign) papillary mesothelioma of the tunica vaginalis.
Chetty R
J Clin Pathol; 1992 Nov; 45(11):1029-30. PubMed ID: 1452778
[TBL] [Abstract][Full Text] [Related]
9. Malignant mesothelioma of the tunica vaginalis testis: a case with a predominant sarcomatous component.
Shimada S; Ono K; Suzuki Y; Mori N
Pathol Int; 2004 Dec; 54(12):930-4. PubMed ID: 15598316
[TBL] [Abstract][Full Text] [Related]
10. Well-differentiated Papillary Mesothelial Tumour of the Tunica Vaginalis Testis - A Rare Lesion, but one Pathologists Should Know About Two Patient Reports and a Review of the Literature.
Kläger J; Oberndorfer F; Brunel C; Veser J; Compérat E
Int J Surg Pathol; 2023 Sep; 31(6):1126-1131. PubMed ID: 36624609
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated papillary mesothelioma occurring in the tunica vaginalis of the testis with contralateral atypical mesothelial hyperplasia.
Tolhurst SR; Lotan T; Rapp DE; Lyon MB; Orvieto MA; Gerber GS; Sokoloff MH
Urol Oncol; 2006; 24(1):36-9. PubMed ID: 16414491
[TBL] [Abstract][Full Text] [Related]
12. Mesothelial lesions of the paratesticular region.
Perez-Ordonez B; Srigley JR
Semin Diagn Pathol; 2000 Nov; 17(4):294-306. PubMed ID: 11202546
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical expression of osteopontin in epithelioid mesotheliomas and reactive mesothelial proliferations.
Tigrani DY; Weydert JA
Am J Clin Pathol; 2007 Apr; 127(4):580-4. PubMed ID: 17369133
[TBL] [Abstract][Full Text] [Related]
14. Practical utility of insulin-like growth factor II mRNA-binding protein 3, glucose transporter 1, and epithelial membrane antigen for distinguishing malignant mesotheliomas from benign mesothelial proliferations.
Chang S; Oh MH; Ji SY; Han J; Kim TJ; Eom M; Kwon KY; Ha SY; Choi YD; Lee CH; Lee Y; Jung SH
Pathol Int; 2014 Dec; 64(12):607-12. PubMed ID: 25376377
[TBL] [Abstract][Full Text] [Related]
15. Benign papillary mesothelioma of the tunica vaginalis testis.
Xiao SY; Rizzo P; Carbone M
Arch Pathol Lab Med; 2000 Jan; 124(1):143-7. PubMed ID: 10629148
[TBL] [Abstract][Full Text] [Related]
16. Well-differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation.
Chen X; Sheng W; Wang J
Histopathology; 2013 Apr; 62(5):805-13. PubMed ID: 23530588
[TBL] [Abstract][Full Text] [Related]
17. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
Friedman MT; Gentile P; Tarectecan A; Fuchs A
Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
[TBL] [Abstract][Full Text] [Related]
18. Oncofetal protein IMP3, a new diagnostic biomarker to distinguish malignant mesothelioma from reactive mesothelial proliferation.
Shi M; Fraire AE; Chu P; Cornejo K; Woda BA; Dresser K; Rock KL; Jiang Z
Am J Surg Pathol; 2011 Jun; 35(6):878-82. PubMed ID: 21566519
[TBL] [Abstract][Full Text] [Related]
19. Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations.
Shivapurkar N; Wiethege T; Wistuba II; Salomon E; Milchgrub S; Muller KM; Churg A; Pass H; Gazdar AF
J Cell Biochem; 1999 Dec; 76(2):181-8. PubMed ID: 10618635
[TBL] [Abstract][Full Text] [Related]
20. Mesothelioma of Uncertain Malignant Potential (MUMP) of the Tunica Vaginalis: Proposal for Reclassification as "Complex Mesothelial Tumor of the Tunica Vaginalis".
Ding CC; Van Roo J; Kryvenko ON; Ye H; McKenney JK; Epstein JI
Am J Surg Pathol; 2024 Apr; 48(4):387-394. PubMed ID: 38270560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
